93 Amendments of Konstantinos ARVANITIS related to 2022/0009(COD)
Amendment 96 #
Proposal for a regulation
Recital 2
Recital 2
(2) The European Monitoring Centre for Drugs and Drug Addiction was set up to provide factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences at Union level to provide the Union and the Member States with evidence to inform policymaking and guide initiatives to tackle drugs and thus give them added value when, in their respective areas of competence, they take measures or decide on action to address the drugs phenomenon. The creationwork of the European Monitoring Centre for Drugs and Drug Addiction has manifestly improved the availability of information on drugs and drug addiction across Europe and internationally.
Amendment 98 #
Proposal for a regulation
Recital 3
Recital 3
(3) Whereas its general objective is still valid and should be retained, Regulation (EC) No 1920/2006 as such no longer fits for addressing the current and future drug challenges. Therefore, the mandate of the European Monitoring Centre for Drugs and Drug Addiction should be revised, including its replacement, strengthening and renaming into “European Union Drugs Agency” (‘the Agency’). Since substantial amendments to Regulation (EC) No 1920/2006 are needed to accommodate the common approach for Union decentralised agencies48to reflect the balanced, evidence-based, integrated and multidisciplinary approach enshrined in the Union strategies on drugs and to take account of the developments of the drug phenomenon, in the interest of clarity and efficiency that Regulation should be replaced by a new Regulation. _________________ 48 Joint Statement of the European Parliament, the Council of the EU and the European Commission on decentralised agencies of 19 July 2012, https://european- union.europa.eu/sites/default/files/docs/bod y/joint_statement_and_common_approach _2012_en.pdf.
Amendment 102 #
Proposal for a regulation
Recital 4
Recital 4
(4) The main focus of Regulation (EC) No 1920/2006 was on health-related issues. However, addressing also drug markets and drug supply issues, is necessary to understand the impacts of the drug phenomenon on public health, reduce the availability of drugs in the Union and curb drug demand. Health- and supply- related issues aby applying a multidisciplinary approach incorporating a human rights, gender equality, public health, health equity, and social perspective in relation to drugs, drug use, drug use disorders and addictions, prevention, treatment, care, risk and harm reduction, abstinence-based recovery, rehabilitation, social re intrinsically linked. The Agency should therefore address the drug phenomenon more holisticallyegration, drug supply, including illicit production and trafficking, and other relevant drug-related issues and their consequences.
Amendment 105 #
Proposal for a regulation
Recital 5
Recital 5
(5) The work of the Agency should be carried out with due regard to the respective powers of the Union and its Member States in the area of drugs. It should cover the various facets of the drugs phenomenon and the solutions applied. In doing so, the Agency should be guided by and reflect the balanced, evidence-based, integrated and multidisciplinary approach enshrined in the relevant strategies and action plans adopted by the Union, in particular the applicable EU Drugs Strategy and Action Plan.
Amendment 107 #
Proposal for a regulation
Recital 6
Recital 6
(6) In pursuing its activities, the Agency should cooperate with other Union agencies and bodies, in particularrelevant Union bodies, offices and agencies within their mandates, such as the European Union Agency for Law Enforcement Cooperation (Europol), the European Union Agency for Law Enforcement Training (CEPOL), the European Union Agency for Criminal Justice Cooperation (Eurojust), the European Medicines Agency (EMA), the European Centre for Disease Prevention and Control (ECDC), and the European Education and Culture Executive Agency (EACEA), and other international bodies, offices and agencies, in particular ECOSOC and the UN Narcotics Board, and should take account of their activities in order to avoid duplication. Cooperation should also take place on an international level with relevant authorities and bodies in third countries and on the United Nations level.
Amendment 110 #
Proposal for a regulation
Recital 6 a (new)
Recital 6 a (new)
(6 a) In order to better address the drugs phenomenon, the Agency should maintain a close dialogue with the scientific community, civil society organisations and other relevant stakeholders.
Amendment 112 #
Proposal for a regulation
Recital 7
Recital 7
(7) Poly-substance use, that is the concomitant use of one or more psychoactive substance or type of substance, whether licit or illicit, when those substances are taken together with drugs, is becoming increasingly common. Therefore, the Agency’s work should addresspay due regard to other substance-based addictions when those substances are taken together with drugs by developing mon, whether licit oring systems that would consider, instead of focusing only on one substance, heroin for example, the important role played by concurrent or sequential use of other substances as well, such as non-controlled opioids or misused medication illicit, are consumed at the same time or sequentially within a short period of time together with drugs.
Amendment 113 #
Proposal for a regulation
Recital 9
Recital 9
(9) The collection, analysis and dissemination of data should continue to be the main task of the Agency. When collecting, analysing and disseminating data, the Agency should pay particular attention to respecting the legal framework on the processing of personal data and should not collect any data which would make it possible to identify individuals or small groups of individuals. The standard data is collected through the national focal points, which should remain one of the main data providers for the Agency. Additional, closer to real-time data sources are increasingly available through innovative data collection methods. Therefore, the Agency should have access to all data available to get a holistic picture of the drug phenomenon in the Union and the external factors influencing it.
Amendment 120 #
Proposal for a regulation
Recital 11
Recital 11
(11) In order to facilitate and structure data collection, information exchange, both qualitative and quantitative, and to support the establishment of an integrated and interoperable monitoring system enabling real-time monitoring, the Agency should have andevelop and apply the appropriate digital solution. This should allow for the automation of data and information management and exchange. Such solution should alss required for the performance of its tasks, among others to facilitate the real- time monitoring of technology-enabled drug markets, including the darknet.
Amendment 123 #
Proposal for a regulation
Recital 16
Recital 16
(16) Based on the strengthened monitoring by the Agency and the experience gained in the risk assessment of new psychoactive substances, the Agency should develop general health and security, inclusion and social reintegration threat assessment capabilities. A more proactive capacity to rapidly identify new threats and inform the development of counter-measures is urgently needed as the dynamic nature of the modern drug phenomenon means that related challenges can rapidly spread across borders.
Amendment 130 #
Proposal for a regulation
Recital 22
Recital 22
(22) Since the Agency has access to data and the necessary scientific experience to develop and promote evidence-based prevention strategies, it should be involved in prevention work, in particular exchange of best practices and implementable research results in drug prevention, drug-related crimeinterventions, best practices and awareness raising, it should be involved in drug prevention and the prevention of drug-related harms, including the elaboration of quality standards for drug prevention (European Drug Prevention Quality Standards) or of a curriculum providing decision- and policy- makers with the knowledge about the most effective evidence-based prevention interventions and approaches (European Union Prevention Curriculum).
Amendment 132 #
Proposal for a regulation
Recital 23
Recital 23
(23) Given its Union perspective, the Agency should be able to evaluate national measures and training, for example on prevention, treatment, harm reduction, abstinence-based recovery and other related measures, in view of their compliance with the latest scientific state of play and of their proven usefulnesscontribution. Member States or relevant professional bodies should be given the possibility to use the accreditation or certification as a quality label for their work.
Amendment 134 #
Proposal for a regulation
Recital 25
Recital 25
(25) The responsibilities of the Agency in the area of international cooperation should be defined in more clear terms in order to allow it to fully engage in such activities and respond to requests from third countries and bodies. The Agency should be able to contribute tooffer adequate scientific and evidence-based tools for the development and implementation of the external dimension of the Union’s drugs policy and the leadership role of the Union at multilateral level as a means to ensure the efficient and coherent implementation of the Union drug policies internally and at international level. In order that the Agency can allocate adequate levels of resources to this task, the work on international cooperation should be part of the core tasks of the Agency. It should be based on an international cooperation framework of the Agency, which should be in line with the Union priorities on international cooperation and should be revised on a regular basis to ensure that it adequately reflects international developments.
Amendment 136 #
Proposal for a regulation
Recital 26
Recital 26
(26) In order to help Union funding for security and health research to develop its full potential and address the needs of drugs policy, the Agency should assist the Commission in identifying key research themes, drawing up and implementing the Union framework programmes for research and innovation that are relevant to the Agency’s objectives. Where the Agency assists the Commission in identifying key research themes, drawing up and implementing a Union framework programme, it should not receive funding from that programme in order to avoid a potential conflict of interest. Finally, the Agency should participate in Union-wide initiatives addressing research and innovation to ensure that technologies necessary for its activities are developed and available for use.
Amendment 138 #
Proposal for a regulation
Recital 27
Recital 27
(27) The Management Board should be assisted by an Executive Board to prepare its decisions. The Agency should be headed by an Executive Director. A Scientific Committee should continue assisting the Management Board and the Executive Director with regard to relevant scientific matters. The importance of gender-balanced representation should be taken into account when appointing people to positions within the administrative and management structure of the Agency.
Amendment 140 #
Proposal for a regulation
Recital 29
Recital 29
(29) The Agency should be properadequately resourced to carry out its tasks and gran. That should be properly reflected in the multiannual financial framework with a dedicated and autonommbitious budget. ItThe Agency should be mainly financed by a contribution from the general budget of the Union. The Union budgetary procedure should be applicable as far as the Union contribution and any other subsidies chargeable to the general budget of the Union are concerned. The auditing of accounts should be undertaken by the Court of Auditors of the European Union.
Amendment 145 #
(30) Fees improve the funding of an agency and may be considerapplied for specific issues that can bare clearly separateddistinct from the core tasks of the aAgency. AnyThe fees levie calculation method should bye the Agency should cover its costs for providingransparent and should ensure coverage of the respective serviceAgency costs.
Amendment 147 #
Proposal for a regulation
Recital 35
Recital 35
(35) The Agency should cooperate closely with relevant international organisations, other governmental and non-governmental bodies and relevant technical bodies from inside and outside the Union in the implementation of its work programme, notably to avoid duplication of work and to ensure access to all data and tools needed for carrying out its mandatemaintain a structured dialogue with relevant civil society organisations.
Amendment 152 #
Proposal for a regulation
Article 3 – paragraph 1 – point 3
Article 3 – paragraph 1 – point 3
(3) ‘poly-substance use’ means the concomitant usesimultaneous or short-interval sequential consumption of one or more psychoactive substances or types of substances, whether illicit or illicit, when those substances are taken together withindicatively medicinal products, alcohol or tobacco and drugs;
Amendment 154 #
Proposal for a regulation
Article 4 – paragraph 1
Article 4 – paragraph 1
The Agency shall provide the Union and its Member States with factual, objective, reliable and comparable information, early warning and risk assessment at Union level concerning drugs, drug addiction, drug markets and their consequences, and to recommend appropriate and concrete, evidence-based actions on how to address the related challenges in a timely manner, including with respect to prevention, treatment, care, risk and harm reduction, abstinence-based recovery, rehabilitation and social reintegration. In carrying out its tasks, the Agency shall take an evidence-based, integrated, balanced and multidisciplinary approach to the drugs phenomenon, incorporating a human rights, gender equality, public health, health equity, and social perspective.
Amendment 156 #
Proposal for a regulation
Article 5 – paragraph 1 – point a – point 1
Article 5 – paragraph 1 – point a – point 1
(1) the collection and analysis of information and data pursuant to Article 6(1);
Amendment 157 #
Proposal for a regulation
Article 5 – paragraph 1 – point a – point 2
Article 5 – paragraph 1 – point a – point 2
(2) the dissemination of information and data, data and results of analyses pursuant to Article 6(5); and
Amendment 159 #
Proposal for a regulation
Article 5 – paragraph 1 – point a – point 3
Article 5 – paragraph 1 – point a – point 3
(3) the monitoring of the drug phenomenon, encompassing the public health, social and human rights, safety and security dimension, pursuant to Article 7.
Amendment 162 #
Proposal for a regulation
Article 5 – paragraph 1 – point b – point 2
Article 5 – paragraph 1 – point b – point 2
(2) health and security threat assessment and preparedness pursuant to Article 12;
Amendment 165 #
Proposal for a regulation
Article 5 – paragraph 1 – point c – point 1
Article 5 – paragraph 1 – point c – point 1
(1) the development, expansion and promotion of Union-wide prevention programmes and campaignsevidence-based interventions, best practices and awareness raising pursuant to Article 16;
Amendment 167 #
Proposal for a regulation
Article 5 – paragraph 4
Article 5 – paragraph 4
4. The Agency shall support and improve coordination between national and Union action in its areas of activity and facilitate exchanges of information between decision-makers, researchers, specialists and those involved in drug-related issues in governmental and non-governmental organisations.
Amendment 169 #
Proposal for a regulation
Article 5 – paragraph 7
Article 5 – paragraph 7
7. In carrying out and implementing the tasks referred to in paragraph 1, the Agency shall cooperate actively with other Union decentralised agencies and bodibodies, offices and agencies within their mandates, in particular Europol, Eurojust, the European Medicines Agency, the European Centre for Disease Prevention and Control, civil society organisationsUnion Agency for Fundamental Rights, the European Union Agency for Law Enforcement Training (CEPOL), the European Medicines Agency, the European Centre for Disease Prevention and Control and the European Foundation for the Improvement in Living and Working Conditions (Eurofound), with other international bodies, offices and agencies, in particular ECOSOC and the UN Narcotics Board, and with the scientific community, academia, civil society organisations, in particular the Civil Society Forum on Drugs, representatives of affected communities, including people who use drugs, and other relevant stakeholders, to attain maximum efficiency in monitoring, assessing and responding to the drugs phenomenon.
Amendment 172 #
Proposal for a regulation
Article 6 – paragraph 1 – point a
Article 6 – paragraph 1 – point a
(a) collect all relevant information and data, including information and data communicated by the national focal points, resulting from research, available from open sources, and data emanating from Union, non-governmental sources and competent international organisations and bodies;
Amendment 173 #
Proposal for a regulation
Article 6 – paragraph 1 – point b
Article 6 – paragraph 1 – point b
(b) collect information and data needed for the monitoring of poly-substance use and its consequences as referred to in Article 7(1), point (ac);
Amendment 177 #
Proposal for a regulation
Article 6 – paragraph 4 – subparagraph 1
Article 6 – paragraph 4 – subparagraph 1
The Agency mayshall develop the necessary digital solutions through which information and data are managed and automatically exchanged. All such solutions shall be developed and implemented in a transparent, just, fair and equitable manner.
Amendment 179 #
Proposal for a regulation
Article 6 – paragraph 4 – subparagraph 2
Article 6 – paragraph 4 – subparagraph 2
Amendment 184 #
Proposal for a regulation
Article 6 – paragraph 5 – point b
Article 6 – paragraph 5 – point b
(b) ensuring wide dissemination of its analysis, conclusions and reports, including to the scientific community, civil society organisations and affected communities, including people who use drugs, with the exception of classified and sensitive non-classified data in accordance with Article 49;
Amendment 188 #
Proposal for a regulation
Article 6 – paragraph 5 a (new)
Article 6 – paragraph 5 a (new)
5 a. Where relevant, the Agency may disseminate information and data disaggregated by Member State, gender, age, race, ethnicity, disability and socio- economic status, in accordance with the relevant national legal framework and Union data protection law. When disseminating such information and data, the Agency shall make reference to the sources thereof.
Amendment 189 #
Proposal for a regulation
Article 6 – paragraph 6
Article 6 – paragraph 6
6. The Agency shall not collect any data making it possible to identify individuals or small groups of individuals. It shall refrain from any transmission ofnot transmit any information relating to specific individuals.
Amendment 192 #
Proposal for a regulation
Article 7 – title
Article 7 – title
Monitoring of the drug phenomenon and sharing of best practices
Amendment 193 #
Proposal for a regulation
Article 7 – paragraph 1 – point a
Article 7 – paragraph 1 – point a
(a) the drugs phenomenon in the Union holistically, through epidemiological and other indicators, covering the health, social and human rights, social reintegration, safety and security aspects, including the implementation of the applicable Union strategies on drugs;
Amendment 196 #
Proposal for a regulation
Article 7 – paragraph 1 – point a a (new)
Article 7 – paragraph 1 – point a a (new)
(a a) evidence-based best practices and innovative approaches regarding health, social and human rights, safety or security responses;
Amendment 201 #
Proposal for a regulation
Article 7 – paragraph 1 – point b
Article 7 – paragraph 1 – point b
(b) emerging trends in the drugs phenomenon in the Union and internationally as far as these impact on the Union; this shall include the monitoring of the use of new technologies for drug services or drug trafficking, and links to other crime areas, as relevant;
Amendment 202 #
Proposal for a regulation
Article 7 – paragraph 1 – point b a (new)
Article 7 – paragraph 1 – point b a (new)
(b a) drug use, drug use disorders, drug addictions and related health risks and harm and emerging trends in those fields;
Amendment 204 #
Proposal for a regulation
Article 7 – paragraph 1 – point c a (new)
Article 7 – paragraph 1 – point c a (new)
(c a) poly-substance use and its consequences, in particular the increased risks of health and social problems, the social determinants of drug use, drug use disorders and addictions, and the implications for policies and responses;
Amendment 206 #
Proposal for a regulation
Article 7 – paragraph 1 – point d a (new)
Article 7 – paragraph 1 – point d a (new)
(d a) drug and poly-substance use and its consequences from a gender perspective, in particular its impact on gender-based violence;
Amendment 209 #
Proposal for a regulation
Article 7 – paragraph 2
Article 7 – paragraph 2
2. Based on its monitoring activities, the Agency shall identify innovative best practices and develop them further. The Agency shall provide and share information on innovative best practices inand develop innovative and evidence-based best practices, share them with the Member States and facilitate the exchange of such practices among the Member Statesm.
Amendment 213 #
Proposal for a regulation
Article 7 – paragraph 3
Article 7 – paragraph 3
3. The Agency shall undertake regular foresight exercises, taking into account the information available. It shall develop, on that basis, relevant predictscenarions for the development of future drugs policy.
Amendment 215 #
Proposal for a regulation
Article 9 – paragraph 2 – point f a (new)
Article 9 – paragraph 2 – point f a (new)
(f a) information on the health-related risks associated with the new psychoactive substances;
Amendment 218 #
Proposal for a regulation
Article 9 – paragraph 4
Article 9 – paragraph 4
4. Where the Agency considers it necessary, it shall request the national focal points or the relevant stakeholders, including the scientific community, civil society organisations and affected communities, to provide additional information on the new psychoactive substance. The national focal points or the relevant stakeholders, as applicable, shall provide that information within twohree weeks of receipt of the request.
Amendment 219 #
Proposal for a regulation
Article 9 – paragraph 10 a (new)
Article 9 – paragraph 10 a (new)
10 a. Where appropriate, the Agency shall disseminate the initial report to the relevant stakeholders, including the scientific community, civil society organisations and affected communities, for awareness-raising purposes.
Amendment 223 #
Proposal for a regulation
Article 10 – paragraph 6 a (new)
Article 10 – paragraph 6 a (new)
6 a. Where appropriate, the Agency shall disseminate the risk assessment report to the relevant stakeholders, including the scientific community, civil society organisations and affected communities, for awareness-raising purposes.
Amendment 225 #
Proposal for a regulation
Article 12 – title
Article 12 – title
Amendment 228 #
Proposal for a regulation
Article 12 – paragraph 1
Article 12 – paragraph 1
1. The Agency shall develop a strategic general health, security, inclusion and reintegration threat assessment capability to identify at an early stage new developments of the drugs phenomenon that have a potential to impact negatively on public health, social aspects, safety and security in the Union and, through doing so, to help increase the preparedness of the relevant stakeholders to respond to new threats in a timely and effective manner.
Amendment 234 #
Proposal for a regulation
Article 12 – paragraph 4
Article 12 – paragraph 4
4. The threat assessment report shall describe the identified threat, the current situation based on available evidence, the potential outcomes in the event of no action, and set out options for preparedness and response that may be adopted to mitigate and to respond to the threat identified, including evidence-based interventions on demand reduction and on risk, harm reduction and abstinence- based recovery. It may also contain potential follow-up measures to be adopted. The threat assessment report shall be sent to the Commission and the Member States, as appropriate.
Amendment 237 #
Proposal for a regulation
Article 12 – paragraph 5
Article 12 – paragraph 5
5. The Agency shall cooperate closely with other Union decentralised agencies and bodies, UnionMember States, other Union bodies, offices and agencies and international organisations in carrying out a threat assessment by involving them in the assessment as appropriate. Where the potential threat is already subject to an analysis under another Union mechanism, the Agency shall not carry out a threat assessment.
Amendment 239 #
Proposal for a regulation
Article 12 – paragraph 6
Article 12 – paragraph 6
6. With the agreement of the Commission, the Agency shall conduct threat assessments on drug related threats emerging from outside the Union, which have the potential to impact public health, social aspects, safety and security within the Union.
Amendment 241 #
Proposal for a regulation
Article 12 – paragraph 6 a (new)
Article 12 – paragraph 6 a (new)
6 a. The Agency shall monitor the evolution of new developments of the drugs phenomenon as referred to in paragraph 1 and update the threat assessments accordingly.
Amendment 244 #
Proposal for a regulation
Article 13 – paragraph 2 – introductory part
Article 13 – paragraph 2 – introductory part
2. Member States shall immediately notify the Agency of any information relating to the appearance of a serious direct or indirect drug-related risk to human healthealth, social aspects, safety or security as well as any information that may be useful for coordinating a response whenever they become aware of such information, such as:
Amendment 247 #
Proposal for a regulation
Article 13 – paragraph 2 – point f a (new)
Article 13 – paragraph 2 – point f a (new)
(f a) social risks;
Amendment 248 #
Proposal for a regulation
Article 13 – paragraph 2 – point f b (new)
Article 13 – paragraph 2 – point f b (new)
(f b) security risks;
Amendment 249 #
Proposal for a regulation
Article 13 – paragraph 3
Article 13 – paragraph 3
3. The Agency shall analyse and assess the available information and data on potential serious risks to human health and complement it with any scientific and technical information it may have available from the early warning system referred to in Article 8 and other threat assessments undertaken in accordance with Article 12, from other Union agencies and bodies and from international organisations, in particular the World Health Organisation. The Agency shall take into account information obtained through its data collection tools and from open source information and consultations with the relevant stakeholders, including the scientific community, civil society organisations and affected communities.
Amendment 253 #
Proposal for a regulation
Article 13 – paragraph 8
Article 13 – paragraph 8
8. The Agency may develop an alert system through which it can directly reachIn close cooperation with the relevant national authorities, in particular the national focal points, and with the relevant stakeholders, including the scientific community, civil society organisations and affected communities, the Agency shall develop and address people who use or potentially use drugslert system to make information on identified risks available to people who use or potentially use particular drugs, where appropriate.
Amendment 254 #
Proposal for a regulation
Article 15 – paragraph 2
Article 15 – paragraph 2
2. The network shall act primarily as a forum for generating data and information exchange on new developments and trends, organising training to enhance the competence of forensic drug and toxicology experts, supporting the implementation of quality assurance schemes and supporting the further harmonisation of data collection and analytical methods.
Amendment 256 #
Proposal for a regulation
Article 15 – paragraph 3
Article 15 – paragraph 3
3. Each Member State shall have the right to appoint, through its representative in the Management Board, two laboratories, one specialising in forensic analysis and one specialising in toxicology, as national representative laboratories to the network. The Agency may select additional laboratories or experts particularly active in the forensic and toxicological investigations of drugs and drug-related harms for specific projects.
Amendment 257 #
Proposal for a regulation
Article 15 – paragraph 5
Article 15 – paragraph 5
5. The network shall closely cooperate with existing networks and organisations active in this area. The network referred to in Article 31 shall be informed regularly and shall take into account their work in order to avoid overlaps. The network referred to in Article 31 shall in that respect be considered a strategic partner and shall be informed regularly, and at least twice a year, about the work of the network of forensic and toxicological laboratories.
Amendment 261 #
Proposal for a regulation
Article 16 – title
Article 16 – title
Amendment 262 #
Proposal for a regulation
Article 16 – paragraph 1
Article 16 – paragraph 1
1. The Agency shall design, develop and promote Union-wide programmes and campaigns for the prevention of drug- related problems and raisingevidence-based interventions and best practices on prevention, risk and harm reduction, abstinence-based recovery, treatment, care and rehabilitation and awareness raising of the adverse effects of drugs. Such interventions, best practices and awareness raising shall be encouraged at the national context, implemented at the national level and targeted at specific groups.
Amendment 265 #
Proposal for a regulation
Article 16 – paragraph 2
Article 16 – paragraph 2
2. The programmes and campaignsinterventions, best practices and awareness raising referred to in paragraph 1 shall be in line with the political orientations set out in the applicable EU Drugs Strategy and Action Plan. They and shall address important dimensions of the drug phenomenensure a balanced approach to demand reduction, shall be targeted to specific groups and be informed by the Agency’s collection of evidence and best practicerm reduction and abstinence-based recovery interventions.
Amendment 266 #
Proposal for a regulation
Article 16 – paragraph 3
Article 16 – paragraph 3
3. The Agency shall develop and promote the implementation of quality standards for drug prevention, risk and harm reduction, abstinence-based recovery, treatment, care and rehabilitation, update them as appropriate and provide or support training pursuant to Article 19.
Amendment 269 #
Proposal for a regulation
Article 16 – paragraph 4
Article 16 – paragraph 4
4. The Agency shall assist Member States in developing national preintervention campaigns in the area of its mandate, including the development of prevention programmes aimed at the reduin relation to the prevention of drug use and the related impacti on ofhealth, drug-related criminality, and prevention of the exploitation of vulnerable groups or individuals within the drug market.
Amendment 272 #
Proposal for a regulation
Article 18 – paragraph 2
Article 18 – paragraph 2
2. The Agency shall support the Member States in implementing their national drug strategies, quality standards and innovative best practices and it shall facilitate exchanges of information between national decision-makauthorities and experts.
Amendment 273 #
Proposal for a regulation
Article 18 – paragraph 3
Article 18 – paragraph 3
3. In supporting policy evaluation, the Agency shall act independently and shall be guided by its scientific standards and an evidence-based approach.
Amendment 276 #
Proposal for a regulation
Article 19 – paragraph 1 – introductory part
Article 19 – paragraph 1 – introductory part
The Agency shall, within the scope of its mandate, in accordance with the staffing and budgetary resources at its disposal and in coordination with other Union decentralised agencibodies, offices and bodagencies:
Amendment 278 #
Proposal for a regulation
Article 20 – paragraph 1 – point f
Article 20 – paragraph 1 – point f
(f) promote the incorporation of all relevant data on drugs and drug addiction gathered in the Member States or emanating from the Union into international monitoring and drug-control programmes, particularly those established by the UN and its specialised agencies, without prejudice to Member States' obligations with regard to transmission of information under the provisions of the United Nations Drug Conventions;
Amendment 282 #
Proposal for a regulation
Article 20 – paragraph 2
Article 20 – paragraph 2
2. The international cooperation framework referred to in paragraph 1, point (a), shall seek to further strengthen and support third countries' efforts to address drug issues in an evidence-based, integrated, balanced and multidisciplinary manner and in full compliance with international human rights obligations. The international cooperation framework shall take into account the relevant policy documents of the Union and consider the developments of the drug phenomenon, in particular trafficking routes and drug production areas. It shall set out the priority countries or regions for cooperation and the key outcomes of the cooperation. It shall take into account the activities undertaken by the Member States. The Agency shall evaluate and review the international cooperation framework regularly.
Amendment 286 #
Proposal for a regulation
Article 20 – paragraph 3 – subparagraph 2
Article 20 – paragraph 3 – subparagraph 2
Technical assistance shall focus in particular on setting up or consolidating national focal points, national data collection systems and national early warning systems and the promotion of best practices in the field of prevention, risk and harm reduction, abstinence- based recovery, treatment, care and rehabilitation, and subsequently assist the creation and strengthening of structural links with the early warning system referred to in Article 8 and the network referred to in Article 31. If the third country so requests, the Agency may provide a certification for these national bodies.
Amendment 289 #
Proposal for a regulation
Article 21 – paragraph 1
Article 21 – paragraph 1
1. The Agency shall assist the Commission and the Member States in identifying key research themes, drawing up and implementing the Union framework programmes for research and innovation activities that are relevant to achieve its general task set out in Article 4. In doing so, the Agency shall pay due attention to the gender dimension and apply intersectionality as a horizontal principle. Where the Agency assists the Commission in identifying key research themes, drawing up and implementing a Union framework programme, the Agency shall not receive funding from that programme.
Amendment 294 #
Proposal for a regulation
Article 23 – paragraph 2 – point a
Article 23 – paragraph 2 – point a
(a) onthree independent experts particularly knowledgeable in the field of drugs designated by the European Parliament, with the right to vote;
Amendment 297 #
Proposal for a regulation
Article 23 – paragraph 3
Article 23 – paragraph 3
3. Each member of the Management Board shall have an alternate. The alternate shall represent the member in her/his absence and shall attend the meetings of the Management Board.
Amendment 306 #
Proposal for a regulation
Article 24 – paragraph 1 – point t
Article 24 – paragraph 1 – point t
(t) approve the list of experts to be used to extend the Scientific Committee in accordance with Article 130(46);
Amendment 311 #
Proposal for a regulation
Article 29 – paragraph 5 – point i
Article 29 – paragraph 5 – point i
(i) protecting the financial interests of the Union by applying preventive measures against fraud, corruption and any other illegal activities, without prejudicing the investigative competence of OLAF and EPPO, by effective checks and, if irregularities are detected, by recovering amounts wrongly paid and, where appropriate, by imposing effective, proportionate and dissuasive administrative, including financial penalties, and by reporting to the EPPO any criminal conduct in respect of which the EPPO could exercise its competence in accordance with Article 24 of Regulation (EU)2017/1939;
Amendment 312 #
Proposal for a regulation
Article 29 – paragraph 6
Article 29 – paragraph 6
6. The Executive Director shall decide whether it is necessary to locate one or more staff in one or more Member States or to send one or more liaison officers to the Union institutions or relevant Union bodies, offices and agencies, for the purpose of carrying out the Agency's tasks in an efficient and effective manner. Before deciding to establish a local or liaison office, the Executive Director shall obtain the prior consent of the Commission, the Management Board and the host Member State(s) concerned. The decision shall specify the scope of the activities to be carried out at the local or liaison office in a manner that avoids unnecessary costs and duplication of administrative functions of the Agency. A headquarters agreement with the host Member State(s) concerned may be concluded.
Amendment 315 #
Proposal for a regulation
Article 30 – paragraph 1
Article 30 – paragraph 1
1. The Scientific Committee shall consist of at mostten to fifteen scientists appointed by the Management Board in view of their scientific excellence and their independence, following the publication of a call for expression of interest in the Official Journal of the European Union. The selection procedure shall ensure that the specialist fields of the members of the Scientific Committee cover the most relevant fields linked to the objectives of the Agency. All parties involved in the selection and appointment of scientists to the Scientific Committee shall aim to achieve a balanced representation between women and men on that committee.
Amendment 317 #
Proposal for a regulation
Article 33 – paragraph 2 – point a a (new)
Article 33 – paragraph 2 – point a a (new)
(a a) depending on their capacity, monitor, analyse and interpret relevant information in the areas covered by Article 4 and provide information on the policies and solutions applied;
Amendment 318 #
Proposal for a regulation
Article 33 – paragraph 2 – point d
Article 33 – paragraph 2 – point d
(d) collect, analyse and interpret in an objective manner at national level all relevant information on drugs, drug addiction, drug markets, drug supply and crime-related issues as well as on policies and solutions applied, needed for the Agency to comply with Article 6. In doing so, the national focal point shall bring together experience from different sectors – in particular health, justice and law enforcement – and shall cooperate with experts and national organisation, national organisations, the scientific community, civil society organisations and other relevant stakeholders active in the field of drugs policy;
Amendment 320 #
Proposal for a regulation
Article 33 – paragraph 2 – point h
Article 33 – paragraph 2 – point h
(h) provide the Agency with information on new trends and challenges in the use of existing psychoactive substances or new combinations of psychoactive substances, which pose a potential risk to public health as well as information on possible measures related to public health;
Amendment 323 #
Proposal for a regulation
Article 33 – paragraph 3
Article 33 – paragraph 3
Amendment 324 #
Proposal for a regulation
Article 33 – paragraph 3 a (new)
Article 33 – paragraph 3 a (new)
3 a. When collecting data pursuant to this Article, the national focal points shall ensure, where possible, that the data collected are disaggregated by gender. The national focal points shall consider the gender-sensitive aspects of drugs policy when collecting and presenting data pursuant to this Article. The national focal points shall not transmit any data which would make it possible to identify individuals or small groups of individuals and any information relating to specific individuals.
Amendment 332 #
Proposal for a regulation
Article 37 – paragraph 1 – introductory part
Article 37 – paragraph 1 – introductory part
1. The Agency may charge third countries fees for the following:
Amendment 334 #
Proposal for a regulation
Article 37 – paragraph 1 – point a
Article 37 – paragraph 1 – point a
(a) training programmesursuant to Article 19;
Amendment 335 #
Proposal for a regulation
Article 37 – paragraph 1 – point b
Article 37 – paragraph 1 – point b
Amendment 339 #
Proposal for a regulation
Article 37 – paragraph 1 – point e
Article 37 – paragraph 1 – point e
(e) other services falling within its mandate and rendered at the request of a participating third country which require the investment of resources in the support of national activities.
Amendment 342 #
Proposal for a regulation
Article 37 – paragraph 2
Article 37 – paragraph 2
2. At the proposal of the Executive Director, the Management Board of the Agency shall in a transparent manner set the amount of the fees and the way in which they are paid.
Amendment 343 #
Proposal for a regulation
Article 37 – paragraph 4
Article 37 – paragraph 4
4. Fees should be set at a level such as to avoid a deficit or a significant accumulation of surplus in the budget. Should a significant positive balance in the budget, resulting from the provision of the services covered by fees, become recurrent, a revision of the level of the fees, or of the Union contribution, shall become mandatory. In case a significant negative balance results from the provision of the services covered by fees, a revision of the level of the fees shall become mandatorymay be revised.
Amendment 348 #
Proposal for a regulation
Article 43 – paragraph 2
Article 43 – paragraph 2
2. The Executive Director shall be appointed by the Management Board, from a list of candidates proposed by the Commission, following an open and transparent selection procedure. Before appointment to a first term, the candidate selected by the Management Board for the post of Executive Director shall be invited, without delay, to make a statement before the European Parliament and answer questions put by its Members.
Amendment 359 #
Proposal for a regulation
Article 55 – paragraph 1
Article 55 – paragraph 1
The Agency shall maintain a closestructured dialogue with relevant civil society organisations active in the fields covered by this Regulation at national, Union or international level for the regular and extensive consultation and exchange of information with civil society organisations. The Agency shall appoint a focal point to manage that structured dialogue, under the authority of the Executive Director.
Amendment 361 #
Proposal for a regulation
Article 55 – paragraph 1 a (new)
Article 55 – paragraph 1 a (new)
The structured dialogue referred to in the first paragraph shall be open to all interested and qualified stakeholders, and it shall include the EU Civil Society Forum on Drugs. To that end, appropriate and sustainable financial means and reinforced administrative support shall be made available to the EU Civil Society Forum on Drugs.